- Victoria
- 13 January 2026 17:11:40
Source: Sharecast
The transaction, carried out on the London Stock Exchange, gave Callaghan a holding of 260,000 shares, representing around 0.23% of the company’s issued share capital, according to the regulatory filing.
Separately, Faron Pharmaceuticals reported that its chief financial officer, Jurriaan Dekkers, sold his entire holding of 4,000 ordinary shares at 182.2p per share on 12 January.
Following the sale, which was executed on AIM, Dekkers no longer holds any shares or voting rights in the clinical-stage immunotherapy company.
Reporting by Josh White for Sharecast.com.
Top Director Buys
Victoria (VCP)
Director name: Callaghan,Stephen James
Amount purchased: 260,000 @ 37.93p
Value: £98,618.00
Guardian Metal Resources (GMET)
Director name: Starzecki ,J.T
Amount purchased: 37,250 @ 149.00p
Value: £55,502.50
Lindsell Train Investment Trust (LTI)
Director name: Lindsell,Michael
Amount purchased: 5,000 @ 648.92p
Value: £32,446.13
Guardian Metal Resources (GMET)
Director name: Friesen,Oliver
Amount purchased: 20,100 @ 148.00p
Value: £29,748.00
Bp (BP.)
Director name: Howle,Carol
Amount purchased: 73 @ 425.60p
Value: £310.69
Centrica (CNA)
Director name: OÂ’Shea,Chris
Amount purchased: 83 @ 180.84p
Value: £150.10
Centrica (CNA)
Director name: O'Brien,Russell
Amount purchased: 83 @ 180.84p
Value: £150.10
Sabre Insurance Group (SBRE)
Director name: Carter,Geoffrey Richard
Amount purchased: 112 @ 133.62p
Value: £149.65
Sthree (STEM)
Director name: Beach,Andrew
Amount purchased: 82 @ 181.81p
Value: £149.08
Croda International (CRDA)
Director name: Foots,Steve
Amount purchased: 5 @ 2,714.00p
Value: £135.70
Bp (BP.)
Director name: Thomson ,Kate
Amount purchased: 5 @ 425.60p
Value: £21.28
Top Director Sells
Faron Pharmaceuticals Oy (di) (FARN)
Director name: Dekkers,Jurriaan
Amount sold: 4,000 @ 182.20p
Value: £7,288.00